newsfilter
← Latest News
ACCESS Newswire·

Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase

SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC:ONPH) Oncology Pharma, Inc. (the "Company") is developing a program to establish the use of its license utilizing NR2F6 agonists and antagonists coupled with the proprietary drug